Y Yan

Crystallization and preliminary X-ray analysis of the Escherichia coli UDP-MurNAc-tripeptide D-alanyl-D-alanine-adding enzyme (MurF).

S. Munshi, Y. Li, B. Leiting, 1999, Acta crystallographica. Section D, Biological crystallography.

Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position.

S. Brady, J. Vacca, S. Gardell, 1998, Journal of medicinal chemistry.

An alternate binding site for the P1-P3 group of a class of potent HIV-1 protease inhibitors as a result of concerted structural change in the 80s loop of the protease.

H. B. Schock, L. Kuo, S. Munshi, 2000, Acta crystallographica. Section D, Biological crystallography.